Profiling the reclassification rates and directions for germline single nucleotide variants in the ClinVar database
Variant / mechanism
Reclassification over time of germline single nucleotide variants submitted to ClinVar
Summary
Using monthly archived ClinVar files, the authors tracked each individual germline single nucleotide variant submission over time, without restriction to phenotype, laboratory or cohort. Of 1,135,194 submissions made between January 2013 and May 2021, 9.90% (112,411) had been reclassified by May 2024. Among ACMG/AMP categories, an initial Likely pathogenic classification had the highest reclassification rate (15.25%) and Benign the lowest (1.59%). Only 10.56% of variants of uncertain significance had been reclassified, although they made up the largest share of initial classifications (48.78%).
Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.
Analysis
The figure that matters in clinic is the one for likely pathogenic variants: more than one in seven changed class, which justifies telling the patient before any irreversible decision based on such a variant. The abstract does not quantify how many reclassifications cross the line between actionable and non-actionable classes; yet that is the figure laboratories need to calibrate their reinterpretation policy.
Analysis by Dr Thibaut Benquey
Why this score?
Clinical impact: 1/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 6/10
Keywords
Every Wednesday · Annotated selection · Free · Unsubscribe anytime